JEXT sol inj 300 mcg auto injecteur

7680613150021 CH-61315 C01CA24 02.05.2.
JEXT sol inj 300 mcg auto injecteur
JEXT sol inj 300 mcg auto injecteur
JEXT sol inj 300 mcg auto injecteur
1 / 3
google

Details

Product number
6131502
CPT
-
Packaging group
1 x 0.3 ml
Unit
Injektor(en), vorgefüllt/Pen
Composition
adrenalinum 300 µg ut adrenalini tartras, natrii chloridum, acidum hydrochloridum q.s. ad pH, E 223 171 µg, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.749 mg.

Articles (1)

Jext 300 Mikrogramm, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1 x 0.3 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/07/2022
Patient information leaflet
Français
26/07/2022
Patient information leaflet
Italien
26/07/2022
Professional SmPC
Allemand
26/07/2022
Professional SmPC
Français
26/07/2022
Professional SmPC
Italien
26/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
171.0 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
0.749 MG Substance HBESI

Reimbursement information

Public price
CHF 67.50
Specialties list
Yes
Generic
No
SL addition date: 01/02/2011

Authorization holder

ALK-Abelló AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
61315
Drug name
Jext 150/300 Mikrogramm, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
C01CA24
Authorization status
Z
Dispensation category
B
First authorization
19/11/2010
Authorization expiration date
31/12/9999
IT number
02.05.2.
Domain
Human medicine
Field of application
Notfallmässige Behandlung von Allergien und Anaphylaxien

Packaging details

Description (FR)
JEXT sol inj 300 mcg auto injecteur
Description (DE)
JEXT Inj Lös 300 mcg Auto Injektor
Market launch
19/11/2010
Narcotic (BTM)
No

Other packaging sizes

JEXT sol inj 150 mcg auto injecteur
1 x 0.15 ml INJ
View